Another child with cancer endangered by alternative medicine: Yesterday, I wrote about the winner of the Nobel Prize in
Another child with cancer endangered by alternative medicine: Yesterday, I wrote about the winner of the Nobel Prize in Physiology or Medicine, Youyou Tu, who, after screening 2,000 herbal treatments from traditional Chinese medicine (TCM) for anti-malaria activity, finally discovered Artemisinin. She...
Source: scienceblogs.com
Migration rules need re-think - NHS boss - BBC News: A re-think of immigration rules which protect ballet dancers but not
Migration rules need re-think - NHS boss - BBC News: A re-think of immigration rules which protect ballet dancers but not vital foreign nurses need re-thinking, the head of the NHS in England says.
Source: bbc.co.uk
NHS meningitis B vaccination programme begins across the UK: Jab to protect against potentially fatal disease has been added
NHS meningitis B vaccination programme begins across the UK: Jab to protect against potentially fatal disease has been added to NHS childhood immunisation programme
Source: theguardian.com
Call for Britain to over-ride patents on Roche cancer drug: A group of patients and campaigners has called on Britain's
Call for Britain to over-ride patents on Roche cancer drug: A group of patients and campaigners has called on Britain's health minister to over-ride patents protecting Roche's expensive breast cancer drug Kadcyla to allow for the import or manufacture of cut-price copies.
Source: reuters.com
Junior doctors: why are you protesting?: Doctors and medical students are set to protest on Monday evening in London against
Junior doctors: why are you protesting?: Doctors and medical students are set to protest on Monday evening in London against proposed changes to trainee’s contracts. Will you be there?
Source: theguardian.com
Sanofi wins EU approval for Praluent anti-cholesterol drug: French drugmaker Sanofi said the European Commission had cleared
Sanofi wins EU approval for Praluent anti-cholesterol drug: French drugmaker Sanofi said the European Commission had cleared its key cholesterol drug Praluent for the treatment of so-called "bad cholesterol," or low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia.
Source: reuters.com
RSS feed